한글목차

개요

의약품 연속 제조 시장(2024-2028)

의약품 연속 제조 시장은 2023-20281년에 5억 4,894만 달러, 예측 기간 중 CAGR은 12.74%로 성장할 것으로 예측됩니다. 의약품 연속 제조 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 제공합니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전반에 관한 최신 분석을 제공하고 있습니다. 만성질환의 증가, 신흥 국가에서 API 제조 시나리오의 진화, 제약 업계에서 지속가능성의 채택 확대 등이 시장을 촉진하고 있습니다.

본 조사에서는 향후 수년간 의약품 연속 제조 시장의 성장을 촉진하는 주요 이유의 하나로 연속 제조에서 디지털화의 진전과 인더스트리 4.0의 통합을 들고 있습니다. 또한 바이오의약품 업계에서 연속 제조의 수요 증가, 아웃소싱 및 수탁제조의 동향 증가는 시장의 큰 수요로 연결됩니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 에코시스템

제3장 시장 규모 파악

• 시장의 정의
• 시장 부문 분석
• 시장 규모 2023
• 시장 전망 2023-2028

제4장 시장 규모 실적

• 세계의 의약품 연속 제조 시장 2018-2022
• 용도별 부문 분석 2018-2022
• 제품별 부문 분석 2018-2022
• 지역별 부문 분석 2018-2022
• 국가별 부문 분석 2018-2022

제5장 Five forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 현황

제6장 시장 세분화 : 용도별

• 시장 부문
• 비교 : 용도별
• 최종 의약품 제조 : 시장 규모와 예측 2023-2028
• 원료의약품 제조 : 시장 규모와 예측 2023-2028
• 시장 기회 : 용도별

제7장 시장 세분화 : 제품별

• 시장 부문
• 비교 : 제품별
• 통합 시스템 : 시장 규모와 예측 2023-2028
• 반연속 시스템 : 시장 규모와 예측 2023-2028
• 컨트롤 또는 소프트웨어 : 시장 규모와 예측 2023-2028
• 시장 기회 : 제품별

제8장 고객 상황

• 고객 상황의 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측 2023-2028
• 유럽 : 시장 규모와 예측 2023-2028
• 아시아 : 시장 규모와 예측 2023-2028
• 세계의 기타 지역 : 시장 규모와 예측 2023-2028
• 미국 : 시장 규모와 예측 2023-2028
• 독일 : 시장 규모와 예측 2023-2028
• 중국 : 시장 규모와 예측 2023-2028
• 영국 : 시장 규모와 예측 2023-2028
• 일본 : 시장 규모와 예측 2023-2028
• 시장 기회 : 지역 상황별

제10장 촉진요인, 과제 및 동향

• 시장 촉진요인
• 시장이 해결해야 할 과제
• 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 구도

• 개요
• 벤더 구도
• 혼란의 상황
• 업계의 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• Coperion GmbH
• Corning Inc.
• Eli Lilly and Co.
• GE Healthcare Technologies Inc.
• GEA Group AG
• Gebruder Lodige Maschinenbau GmbH
• Honeywell International Inc.
• Hosokawa Micron Corp.
• L.B. Bohle Maschinen und Verfahren GmbH
• Novartis AG
• Pfizer Inc.
• Siemens AG
• SK Inc.
• Syntegon Technology GmbH
• Thermo Fisher Scientific Inc.

제13장 부록

영문목차

Abstract

Pharmaceutical Continuous Manufacturing Market 2024-2028

The pharmaceutical continuous manufacturing market is forecasted to grow by USD 548.94 mn during 2023-2028, accelerating at a CAGR of 12.74% during the forecast period. The report on the pharmaceutical continuous manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, evolving API manufacturing scenario in developing countries, and increasing adoption of sustainability in pharmaceutical industry.

Technavio's pharmaceutical continuous manufacturing market is segmented as below:

By Application

• Final drug product manufacturing
• API manufacturing

By Product

• Integrated systems
• Semi-continuous systems
• Controls or software

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing digitalization and integration of industry 4.0 in continuous manufacturing as one of the prime reasons driving the pharmaceutical continuous manufacturing market growth during the next few years. Also, increasing demand for continuous manufacturing in biopharmaceutical industry and growing trend of outsourcing and contract manufacturing will lead to sizable demand in the market.

The report on the pharmaceutical continuous manufacturing market covers the following areas:

• Pharmaceutical continuous manufacturing market sizing
• Pharmaceutical continuous manufacturing market forecast
• Pharmaceutical continuous manufacturing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceutical continuous manufacturing market vendors that include Chemtrix BV, Continuus Pharmaceuticals, Coperion GmbH, Corning Inc., Dr. Helmut Rothenberger Holding GmbH, Eli Lilly and Co., Freund Vector Corp., GE Healthcare Technologies Inc., GEA Group AG, Gebruder Lodige Maschinenbau GmbH, Gericke AG, Honeywell International Inc., Hosokawa Micron Corp., Hovione, KORSCH AG, L.B. Bohle Maschinen und Verfahren GmbH, LMT Group, Novartis AG, Pfizer Inc., Siemens AG, SK Inc., Syntegon Technology GmbH, and Thermo Fisher Scientific Inc.. Also, the pharmaceutical continuous manufacturing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global pharmaceutical continuous manufacturing market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global pharmaceutical continuous manufacturing market 2018 - 2022 ($ million)
• 4.2 Application Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
• 4.3 Product Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

• 6.1 Market segments
• Exhibit 30: Chart on Application - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
• 6.2 Comparison by Application
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application
• 6.3 Final drug product manufacturing - Market size and forecast 2023-2028
• Exhibit 34: Chart on Final drug product manufacturing - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Final drug product manufacturing - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Final drug product manufacturing - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Final drug product manufacturing - Year-over-year growth 2023-2028 (%)
• 6.4 API manufacturing - Market size and forecast 2023-2028
• Exhibit 38: Chart on API manufacturing - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on API manufacturing - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on API manufacturing - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on API manufacturing - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Application
• Exhibit 42: Market opportunity by Application ($ million)
• Exhibit 43: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Product

• 7.1 Market segments
• Exhibit 44: Chart on Product - Market share 2023-2028 (%)
• Exhibit 45: Data Table on Product - Market share 2023-2028 (%)
• 7.2 Comparison by Product
• Exhibit 46: Chart on Comparison by Product
• Exhibit 47: Data Table on Comparison by Product
• 7.3 Integrated systems - Market size and forecast 2023-2028
• Exhibit 48: Chart on Integrated systems - Market size and forecast 2023-2028 ($ million)
• Exhibit 49: Data Table on Integrated systems - Market size and forecast 2023-2028 ($ million)
• Exhibit 50: Chart on Integrated systems - Year-over-year growth 2023-2028 (%)
• Exhibit 51: Data Table on Integrated systems - Year-over-year growth 2023-2028 (%)
• 7.4 Semi-continuous systems - Market size and forecast 2023-2028
• Exhibit 52: Chart on Semi-continuous systems - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on Semi-continuous systems - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on Semi-continuous systems - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Semi-continuous systems - Year-over-year growth 2023-2028 (%)
• 7.5 Controls or software - Market size and forecast 2023-2028
• Exhibit 56: Chart on Controls or software - Market size and forecast 2023-2028 ($ million)
• Exhibit 57: Data Table on Controls or software - Market size and forecast 2023-2028 ($ million)
• Exhibit 58: Chart on Controls or software - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Controls or software - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by Product
• Exhibit 60: Market opportunity by Product ($ million)
• Exhibit 61: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 China - Market size and forecast 2023-2028
• Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.10 UK - Market size and forecast 2023-2028
• Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.11 Japan - Market size and forecast 2023-2028
• Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ million)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 Coperion GmbH
• Exhibit 111: Coperion GmbH - Overview
• Exhibit 112: Coperion GmbH - Product / Service
• Exhibit 113: Coperion GmbH - Key offerings
• 12.4 Corning Inc.
• Exhibit 114: Corning Inc. - Overview
• Exhibit 115: Corning Inc. - Business segments
• Exhibit 116: Corning Inc. - Key news
• Exhibit 117: Corning Inc. - Key offerings
• Exhibit 118: Corning Inc. - Segment focus
• 12.5 Eli Lilly and Co.
• Exhibit 119: Eli Lilly and Co. - Overview
• Exhibit 120: Eli Lilly and Co. - Product / Service
• Exhibit 121: Eli Lilly and Co. - Key news
• Exhibit 122: Eli Lilly and Co. - Key offerings
• 12.6 GE Healthcare Technologies Inc.
• Exhibit 123: GE Healthcare Technologies Inc. - Overview
• Exhibit 124: GE Healthcare Technologies Inc. - Business segments
• Exhibit 125: GE Healthcare Technologies Inc. - Key offerings
• Exhibit 126: GE Healthcare Technologies Inc. - Segment focus
• 12.7 GEA Group AG
• Exhibit 127: GEA Group AG - Overview
• Exhibit 128: GEA Group AG - Business segments
• Exhibit 129: GEA Group AG - Key offerings
• Exhibit 130: GEA Group AG - Segment focus
• 12.8 Gebruder Lodige Maschinenbau GmbH
• Exhibit 131: Gebruder Lodige Maschinenbau GmbH - Overview
• Exhibit 132: Gebruder Lodige Maschinenbau GmbH - Product / Service
• Exhibit 133: Gebruder Lodige Maschinenbau GmbH - Key offerings
• 12.9 Honeywell International Inc.
• Exhibit 134: Honeywell International Inc. - Overview
• Exhibit 135: Honeywell International Inc. - Business segments
• Exhibit 136: Honeywell International Inc. - Key news
• Exhibit 137: Honeywell International Inc. - Key offerings
• Exhibit 138: Honeywell International Inc. - Segment focus
• 12.10 Hosokawa Micron Corp.
• Exhibit 139: Hosokawa Micron Corp. - Overview
• Exhibit 140: Hosokawa Micron Corp. - Business segments
• Exhibit 141: Hosokawa Micron Corp. - Key offerings
• Exhibit 142: Hosokawa Micron Corp. - Segment focus
• 12.11 L.B. Bohle Maschinen und Verfahren GmbH
• Exhibit 143: L.B. Bohle Maschinen und Verfahren GmbH - Overview
• Exhibit 144: L.B. Bohle Maschinen und Verfahren GmbH - Product / Service
• Exhibit 145: L.B. Bohle Maschinen und Verfahren GmbH - Key offerings
• 12.12 Novartis AG
• Exhibit 146: Novartis AG - Overview
• Exhibit 147: Novartis AG - Business segments
• Exhibit 148: Novartis AG - Key offerings
• Exhibit 149: Novartis AG - Segment focus
• 12.13 Pfizer Inc.
• Exhibit 150: Pfizer Inc. - Overview
• Exhibit 151: Pfizer Inc. - Product / Service
• Exhibit 152: Pfizer Inc. - Key news
• Exhibit 153: Pfizer Inc. - Key offerings
• 12.14 Siemens AG
• Exhibit 154: Siemens AG - Overview
• Exhibit 155: Siemens AG - Business segments
• Exhibit 156: Siemens AG - Key news
• Exhibit 157: Siemens AG - Key offerings
• Exhibit 158: Siemens AG - Segment focus
• 12.15 SK Inc.
• Exhibit 159: SK Inc. - Overview
• Exhibit 160: SK Inc. - Product / Service
• Exhibit 161: SK Inc. - Key offerings
• 12.16 Syntegon Technology GmbH
• Exhibit 162: Syntegon Technology GmbH - Overview
• Exhibit 163: Syntegon Technology GmbH - Product / Service
• Exhibit 164: Syntegon Technology GmbH - Key offerings
• 12.17 Thermo Fisher Scientific Inc.
• Exhibit 165: Thermo Fisher Scientific Inc. - Overview
• Exhibit 166: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 167: Thermo Fisher Scientific Inc. - Key news
• Exhibit 168: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 169: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 170: Inclusions checklist
• Exhibit 171: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 172: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 173: Research methodology
• Exhibit 174: Validation techniques employed for market sizing
• Exhibit 175: Information sources
• 13.5 List of abbreviations
• Exhibit 176: List of abbreviations